Literature DB >> 32056430

Synthesis and Biological Evaluation of 4'-Substituted Kaempfer-3-ols.

Sugyeom Kim1, Yu Li1, Lin Lin1, Peyton R Sayasith1, Ariel T Tarr1, Eric B Wright, Sharia Yasmin, Deborah A Lannigan, George A O'Doherty1.   

Abstract

The synthesis of two series of five kaempfer-3-ols was described. The first set all have a C-3 hydroxyl group and the second has a carboxymethoxy ether at the C-3 position. Both series have variable substitution at the C-4' position (i.e., OH, Cl, F, H, OMe). Both kaempferols and carboxymethoxy ethers were evaluated for their ability to inhibit ribosomal s6 kinase (RSK) activity and cancer cell proliferation.

Entities:  

Mesh:

Year:  2020        PMID: 32056430      PMCID: PMC7285650          DOI: 10.1021/acs.joc.9b03461

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  31 in total

1.  Synthesis of a potent and selective inhibitor of p90 Rsk.

Authors:  David J Maloney; Sidney M Hecht
Journal:  Org Lett       Date:  2005-03-17       Impact factor: 6.005

2.  Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.

Authors:  Jeffrey A Smith; Celeste E Poteet-Smith; Yaming Xu; Timothy M Errington; Sidney M Hecht; Deborah A Lannigan
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

3.  Exploiting the therapeutic potential of 8-β-d-glucopyranosylgenistein: synthesis, antidiabetic activity, and molecular interaction with islet amyloid polypeptide and amyloid β-peptide (1-42).

Authors:  Ana R Jesus; Catarina Dias; Ana M Matos; Rodrigo F M de Almeida; Ana S Viana; Filipa Marcelo; Rogério T Ribeiro; Maria P Macedo; Cristina Airoldi; Francesco Nicotra; Alice Martins; Eurico J Cabrita; Jesús Jiménez-Barbero; Amélia P Rauter
Journal:  J Med Chem       Date:  2014-11-12       Impact factor: 7.446

4.  Synthesis of xanthohumol analogues and discovery of potent thioredoxin reductase inhibitor as potential anticancer agent.

Authors:  Baoxin Zhang; Dongzhu Duan; Chunpo Ge; Juan Yao; Yaping Liu; Xinming Li; Jianguo Fang
Journal:  J Med Chem       Date:  2015-02-06       Impact factor: 7.446

5.  Design, synthesis and exploring the quantitative structure-activity relationship of some antioxidant flavonoid analogues.

Authors:  Sreeparna Das; Indrani Mitra; Shaikh Batuta; Md Niharul Alam; Kunal Roy; Naznin Ara Begum
Journal:  Bioorg Med Chem Lett       Date:  2014-09-17       Impact factor: 2.823

6.  B-ring substituted 5,7-dihydroxyflavonols with high-affinity binding to P-glycoprotein responsible for cell multidrug resistance.

Authors:  A Boumendjel; F Bois; C Beney; A M Mariotte; G Conseil; A Di Pietro
Journal:  Bioorg Med Chem Lett       Date:  2001-01-08       Impact factor: 2.823

7.  Structure-activity relationship studies of flavonol analogues on pollen germination.

Authors:  Alaina M Forbes; G Patrick Meier; Stacey Haendiges; Loverine P Taylor
Journal:  J Agric Food Chem       Date:  2014-02-27       Impact factor: 5.279

8.  Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer.

Authors:  Katarzyna A Ludwik; J Preston Campbell; Mingzong Li; Yu Li; Zachary M Sandusky; Lejla Pasic; Miranda E Sowder; David R Brenin; Jennifer A Pietenpol; George A O'Doherty; Deborah A Lannigan
Journal:  Mol Cancer Ther       Date:  2016-08-15       Impact factor: 6.261

9.  Synthesis of carbasugar C-1 phosphates via Pd-catalyzed cyclopropanol ring opening.

Authors:  Mingde Shan; George A O'Doherty
Journal:  Org Lett       Date:  2008-07-18       Impact factor: 6.005

10.  Induction of Apoptosis in MCF-7 Cells via Oxidative Stress Generation, Mitochondria-Dependent and Caspase-Independent Pathway by Ethyl Acetate Extract of Dillenia suffruticosa and Its Chemical Profile.

Authors:  Yin Sim Tor; Latifah Saiful Yazan; Jhi Biau Foo; Agustono Wibowo; Norsharina Ismail; Yoke Kqueen Cheah; Rasedee Abdullah; Maznah Ismail; Intan Safinar Ismail; Swee Keong Yeap
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.